4//SEC Filing
MORGENTHALER PARTNERS VII LP 4
Accession 0001209191-05-044899
CIK 0001183765other
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 6:49 PM ET
Size
7.3 KB
Accession
0001209191-05-044899
Insider Transaction Report
Form 4
Christoffersen Ralph E
Director10% Owner
Transactions
- Sale
Common Stock
2005-08-25$8.84/sh−1,244,344$11,000,001→ 2,309,382 total(indirect: See Footnote 1)
MORGENTHALER PARTNERS VII LP
10% Owner
Transactions
- Sale
Common Stock
2005-08-25$8.84/sh−1,244,344$11,000,001→ 2,309,382 total(indirect: See Footnote 1)
Footnotes (1)
- [F1]The shares are held by Morgenthaler VII, LP (MP VII). Ralph E. Christoffersen, a director of Threshold Pharmaceuticals, Inc., is a Partner of Morgenthaler Management Partners VII, LLC (MMP VII), the managing partner of MP VII. Dr. Christoffersen shares voting power over the shares with the other members of MMP VII. The natural persons who have voting or investment power over the shares held of record of MP VII are Robert C. Bellas, Jr., Greg E. Blonder, James W. Broderick, Ralph E. Christoffersen, Andrew S. Lanza, Theodore A. Laufik, Paul H. Levine, Gary R. Little, John D. Lutsi, Gary J. Morgenthaler, Robert V. Pavey, G. Gary Shaffer and Peter G. Taft. Dr. Christoffersen disclaims beneficial ownership of the shares held by MP VII except to the extent of his pecuniary interest therein.
Documents
Issuer
THRESHOLD PHARMACEUTICALS INC
CIK 0001183765
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001162183
Filing Metadata
- Form type
- 4
- Filed
- Aug 28, 8:00 PM ET
- Accepted
- Aug 29, 6:49 PM ET
- Size
- 7.3 KB